Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1997

View Archived Issues

New antioxidants from Shiseido

Natural products for the treatment of BPH

MS&D reveals nonpeptide tachykinin antagonists

Metabotropic glutamate receptor modulators from Lilly

SmithKline Beecham focuses on hemoregulatory compounds

MMP and TNF production inhibitors described by DuPont Merck

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

Mirapex now available in U.S.

Didronel PMO now available for expanded use in the U.K.

Losec available in U.K. for symptoms of dyspepsia

Dovonex cleared for use in children in the U.K.

Novel antitumor agents from Sanwa Kagaku

DuPont Merck investigates new approach to potent HIV protease inhibitors

Low-dose combination of ramipril and felodipine evaluated in SHR

JL-13 possesses atypical antipsychotic profile

ChiRex to purchase Glaxo Wellcome manufacturing site

Inositol for psychiatric disorders

Transcell and Merck & Co. collaborate on antibacterial research

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

Transdermal xanomeline in development for Alzheimer's disease

MGI Pharma launches INFeD for anemia in cancer patients

Immunex receives approval to market paclitaxel in Canada

NKH-477 possesses antidepressant effects

Perospirone vs. mosapramine for schizophrenia

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

Promising preliminary results from open trial of lamotrigine in depression

Jenner Technologies reports results from phase I/II trial of prostate cancer vaccine

ABS and Chinese Academy of Medical Science expand alliance

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
New orphan drug, CSL’s garadacimab, cleared for hereditary angioedema
BioWorld
Following a complete response letter issued last October over CMC issues, CSL Behring LLC gained U.S. FDA approval June 16 of its humanized anti-factor XIIa...